Neucomed GmbH, founded in 2016, to develop and market medical devices for the treatment of cardiac, neurological and respiratory disorders. Our inital focus is the diagnostic and treatment of epilepsy, sleep apnea, heart failure, structural heart and infectious diseases affecting several million patients worldwide. In addition to our own product developments we help global innovative companies to access the european market. We support the CE marking process and help dealing with competent authorities and notified bodies. As authorized representative, designated by the manufacturers, we use our european distribution network and our direct affiliates. Neucomed is part of GENAERO Group. GENAERO, with its brands TEST-FUCHS and NEUCOMED is a privately-owned group with more than 600 employees and offices in Austria, Germany, UK, France, Italy, Spain, USA and Singapore, TEST-FUCHS is designing and manufacturing aircraft and aerospace testing systems, equipment and components. Neucomed GmbH Donau-City-Straße 7/26 Austria, 1220 Vienna Neucomed Deutschland GmbH Albert-Einstein-Straße 3 Germany, 85435 Erding Neucomed Schweiz GmbH c/o BDO AG Industriestrasse 53 Switzerland, 6312 Steinhausen